# Phase I Clinical Trial of CDP1 in Patients With Advanced Solid Tumors

> **NCT04151810** · PHASE1 · COMPLETED · sponsor: **Dragonboat Biopharmaceutical Company Limited** · enrollment: 32 (actual)

## Conditions studied

- Advanced Tumors

## Interventions

- **DRUG:** CDP1
- **DRUG:** CDP1
- **DRUG:** TIP chemotherapy

## Key facts

- **NCT ID:** NCT04151810
- **Lead sponsor:** Dragonboat Biopharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-16
- **Primary completion:** 2022-10-13
- **Final completion:** 2022-10-13
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04151810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04151810, "Phase I Clinical Trial of CDP1 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04151810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*